Anti-tuberculosis Treatment-Induced Insulin Autoimmune Syndrome.
10.12771/emj.2016.39.4.122
- Author:
Jung Suk HAN
1
;
Han Ju MOON
;
Jin Seo KIM
;
Hong Il KIM
;
Cheol Hyeon KIM
;
Min Joo KIM
Author Information
1. Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea. chorong24@gmail.com
- Publication Type:Case Report
- Keywords:
Hypoglycemia;
Insulin autoimmune syndrome;
Tuberculosis
- MeSH:
Glycine;
Hyperinsulinism;
Hypoglycemia;
Insulin*;
Methimazole;
Tuberculosis
- From:The Ewha Medical Journal
2016;39(4):122-124
- CountryRepublic of Korea
- Language:English
-
Abstract:
Insulin autoimmune syndrome, a rare cause of endogenous hyperinsulinemic hypoglycemia, is characterized by insulin autoantibody, hyperinsulinemia and fasting hypoglycemia. It is well known that drugs containing a sulfhydryl group such as methimazole or α-mercaptopropionyl glycine can induce insulin autoimmune syndrome. However, insulin autoimmune syndrome caused by anti-tuberculosis treatment is very rare. We report a case of insulin autoimmune syndrome after anti-tuberculosis treatment with a review of the relevant literature.
